ResearcherHong Kong Baptist UniversityActive in the last 2 years
Fangfei Li
Matched on ORCID iD 0000-0003-2710-7089; OpenAlex author ID A5100763319. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 4
- Therapeutic potential of flavonoids from traditional Chinese medicine in pancreatic cancer treatment. Last author DOI 10.3389/fnut.2024.1477140↗
- Inflammatory Processes: Key Mediators of Oncogenesis and Progression in Pancreatic Ductal Adenocarcinoma (PDAC). Last author DOI 10.3390/ijms252010991↗
- Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer. Last author DOI 10.3390/ijms241713539↗
- Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy. Co-author DOI 10.3389/fcell.2022.855474↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aiping Lü · 4 shared papers, 2022–2024 · strength 0.92
- Paper Inflammatory Processes: Key Mediators of Oncogenesis and Progression in Pancreatic Ductal Adenocarcinoma (PDAC). DOI 10.3390/ijms252010991↗
- Paper Therapeutic potential of flavonoids from traditional Chinese medicine in pancreatic cancer treatment. DOI 10.3389/fnut.2024.1477140↗
- Paper Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer. DOI 10.3390/ijms241713539↗
- Ge Zhang · 2 shared papers, 2022–2024 · strength 0.45
- Yang Liu · 1 shared paper, 2024 · strength 0.28
- Qi Wan · 1 shared paper, 2024 · strength 0.26
- Zhen Chen · 1 shared paper, 2023 · strength 0.20
- Xiaoqiu Wu · 1 shared paper, 2022 · strength 0.17
- Hong Dai · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.